Oliver Weingärtner Selected Research

campesterol

11/2022	Increased cholesterol absorption is associated with In-stent-restenosis after stent implantation for stable coronary artery disease.
9/2011	Markers of enhanced cholesterol absorption are a strong predictor for cardiovascular diseases in patients without diabetes mellitus.
9/2009	Alterations in cholesterol homeostasis are associated with coronary heart disease in patients with aortic stenosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Oliver Weingärtner Research Topics

Disease

12	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 09/2009
5	Atherosclerosis 01/2017 - 04/2008
4	Aortic Valve Stenosis (Aortic Stenosis) 07/2015 - 04/2008
3	Coronary Artery Disease (Coronary Atherosclerosis) 11/2022 - 07/2015
3	Hypercholesterolemia 01/2017 - 09/2011
2	Dyslipidemias (Dyslipidemia) 01/2021 - 01/2011
2	Hypertension (High Blood Pressure) 09/2011 - 01/2009
1	Pathologic Constriction (Stenosis) 11/2022
1	Peripheral Arterial Disease 01/2022
1	Inflammation (Inflammations) 12/2021
1	COVID-19 12/2021
1	Chest Pain (Chest Pains) 12/2021
1	Myocarditis (Carditis) 12/2021
1	Infections 12/2021
1	Chronic Renal Insufficiency 01/2017
1	Sitosterolemia 04/2014
1	Amyloid Plaque 10/2013
1	Alzheimer Disease (Alzheimer's Disease) 10/2013
1	Diabetes Mellitus 09/2011
1	Hyperplasia 01/2011
1	Carotid Artery Injuries 01/2011
1	Hypertriglyceridemia 01/2011
1	Vascular Remodeling 01/2011
1	Cerebrotendinous Xanthomatosis 03/2010
1	Vascular Diseases (Vascular Disease) 09/2009
1	Coronary Disease (Coronary Heart Disease) 09/2009
1	Respiratory Sounds (Crackle) 01/2009
1	Angioedema 01/2009
1	Brain Injuries (Brain Injury) 04/2008

Drug/Important Bio-Agent (IBA)

14	CholesterolIBA 11/2022 - 09/2009
9	Phytosterols (Plant Sterols)IBA 01/2021 - 04/2008
8	LipidsIBA 11/2022 - 10/2010
4	lathosterolIBA 11/2022 - 09/2009
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2022 - 09/2011
3	campesterolIBA 11/2022 - 09/2009
2	Ezetimibe (Zetia)FDA Link 11/2022 - 11/2020
2	LDL CholesterolIBA 01/2020 - 01/2019
2	oxidized low density lipoproteinIBA 01/2020 - 01/2011
2	SterolsIBA 06/2011 - 04/2008
1	2019-nCoV Vaccine mRNA-1273IBA 12/2021
1	Troponin T (Troponin T1)IBA 12/2021
1	Nucleocapsid ProteinsIBA 12/2021
1	VaccinesIBA 12/2021
1	Immunoglobulin G (IgG)IBA 12/2021
1	dibenzthione (D 47)IBA 01/2021
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2020
1	Apolipoproteins B (ApoB)IBA 01/2020
1	EstersIBA 01/2017
1	MargarineIBA 01/2017
1	Indicators and Reagents (Reagents)IBA 07/2015
1	Cholestanol (Coprostanol)IBA 07/2015
1	OxysterolsIBA 05/2015
1	gamma-sitosterol (beta-sitosterol)IBA 05/2015
1	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2015
1	Amyloid (Amyloid Fibrils)IBA 10/2013
1	Proteins (Proteins, Gene)FDA Link 10/2013
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 10/2013
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2011
1	1,4-dihydropyridine (dihydropyridine)IBA 01/2011
1	Cholestanetriol 26-Monooxygenase (Cholestanetriol 26 Monooxygenase)IBA 03/2010
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2009
1	Histamine Antagonists (Antihistamines)IBA 01/2009
1	Epinephrine (Adrenaline)FDA LinkGeneric 01/2009
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2009
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2009

Therapy/Procedure

4	Therapeutics 01/2022 - 01/2011
1	Stents 11/2022
1	Aftercare (After-Treatment) 01/2009